menu
    • menu

    Company profile for Cerevance

    NEW Drugs in Dev: 4
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The world desperately needs new therapies for neurological and psychiatric diseases that work through novel mechanisms of action. Discovering a new treatment usually starts with identifying a target protein that is involved in the biological pathways or tissues affected by a disease. Researchers then use chemistry or other methods to change that target protein’s activity while not directly affecting other proteins.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CerevanceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Marina Park Drive Suite 1410 Boston, MA 02210
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cerevance.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cerevance
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cerevance/media

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cerevance To Unveil Solengepras Phase 2 Results In Parkinson
    Cerevance To Unveil Solengepras Phase 2 Results In Parkinson

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252742/0/en/Cerevance-to-Present-Phase-2-Trial-Results-on-OFF-Time-and-Sleep-Related-Outcomes-with-Solengepras-in-Parkinson-s-Disease-at-AD-PD-2026.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    Cerevance To Present At TD Cowen Health Care Conference
    Cerevance To Present At TD Cowen Health Care Conference

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242544/0/en/Cerevance-to-Participate-in-the-TD-Cowen-46th-Annual-Health-Care-Conference.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Cerevance Joins RBC Capital Markets 2025 Healthcare Conference
    Cerevance Joins RBC Capital Markets 2025 Healthcare Conference

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196954/0/en/Cerevance-to-Participate-in-RBC-Capital-Markets-2025-Healthcare-Private-Company-Conference.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Cerevance To Showcase Solengepras In Parkinson's At PSG Meeting
    Cerevance To Showcase Solengepras In Parkinson's At PSG Meeting

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193435/0/en/Cerevance-to-Highlight-Potential-of-Solengepras-in-Parkinson-s-Disease-at-the-2025-Parkinson-Study-Group-Annual-Meeting.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Cerevance Joins TD Cowen Summit On Obesity Treatments
    Cerevance Joins TD Cowen Summit On Obesity Treatments

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3189075/0/en/Cerevance-to-Participate-in-the-TD-Cowen-Treatment-Advancements-in-Obesity-and-Related-Disorders-Summit.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share
    Cerevance To Unveil Solengepras Phase 2 Data For Parkinson's
    Cerevance To Unveil Solengepras Phase 2 Data For Parkinson's

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3153862/0/en/Cerevance-to-Present-Phase-2-Data-on-Solengepras-in-Parkinson-s-Disease-at-the-2025-International-Congress-of-Parkinson-s-Disease-and-Movement-Disorders.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search